Hypolipidemic activity evaluation of DRF/AY/4013, an herbal formulation in experimentally induced hyperlipidemic rats

Journal of Complementary and Integrative Medicine

Volumn 5, Issue 1, 2008, Pages

  Gajbhiye, Sagarika Shankar ^a   Naik, Suresh ^b   Sharma, G ^c   Kohli, K ^c  

^a PRIN K M KUNDNANI COLLEGE OF PHARMACY   (India)

^b Singhad College of Pharmaceutical Sciences

^c DABUR RESEARCH FOUNDATION   (India)

Author keywords

Cardiovascular diseases; Cardiovascular risks; Experimental rat models; Herbal product; Hyperlipidemia; Hypolipidemic activity; Rats

Indexed keywords

ATORVASTATIN; DRF AY 4013; LIPID; LIPOPROTEIN; PLANT EXTRACT; PROPYLTHIOURACIL; TERMINALIA ARJUNA EXTRACT; TYLOXAPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENIC DIET; CELL INFILTRATION; CONTROL GROUP; CONTROLLED STUDY; CYTOPLASM; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; EXPERIMENTAL MODEL; HERBAL MEDICINE; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; LIVER CELL; NONHUMAN; RAT;

EID: 48749089004     PISSN: 15533840     EISSN: None     Source Type: Journal    
DOI: 10.2202/1553-3840.1148     Document Type: Article

References (29)

1. Alpana, R., Lauria P., Gupta R., Kumar P. and Sharma, V.N., Hypocholesterolaemic effects of Terminalia Arjuna tree bark. Jour. Ethnopharmacology, (1997), 55:165-169.
2. Banerjee, K.S. and Maulik K.S., Effect of garlic on cardiovascular disorders:a review, Nutrition Journal, (2002), 1(4): 1-14.
3. Brown, M.S., Kovanen, P.T. and Goldstein, J.L.,Regulation of plasma cholesterol by lipoprotein receptors. Science, (1981), 212: 628-635.
4. Dhuley, J. N., Naik, S.R., Rele, S. and Banerji, A., Hypolipidaemic and antioxidant activity of diallyl disulphide in rats, Pharm. Phamacol. Commun., (1999), 5 : 689-696.
5. Friedman, M. and Bayer, S.O., The mechanism underlying hypocholesterolemia induced by Triton WR 1339, American Jour. Physiology, (1957),190: 439-445.
6. Gerd A., Antonio, M. Gotto., HDL Cholesterol and Protective Factors in Atheroclerosis, Circulation, (2004), 109, III 8-III 14.
7. Golan,D.E., Tashjian, A.H, Armstong,E.J., Galanter,J.M., Armstrong, A.W, Ramy,A.A. and Rose, H.S. Principles of Pharmacology. The pathophysiologic basics of drug therapy,(2005), Lippincott Williams and Wilkins, USA, 357-373.
8. Govindarajan, R., Agnihotri, A.K., Khatoon, S., Rawat, A.K.S., Pharmagnostical evaluation of an antioxidant plant-Acorus calamus. Natural Prod. Sci., (2003), 9: 264-269.
9. Jones, J. M. and Lee Chambliss, Hypertriglyceridemia and Coronary Heart Disease, Arch Fam Med., (2000), 9: 189-190.
10. Kapoor, L.D,CRC Handbook of Ayurvedic Medicine Plants,(1990), Boca Raton (FL) CRC Press, USA.
11. Khanna, A.K,Rizvi,.F, Chander,R., Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. Jour. Ethnopharmacology, (2002), 82: 19-22.
12. Khanna, A.K., Ramesh, C. and Kapoor, N.K., Terminalia arjuna: an Ayurvedic cardiotonic regulates lipid metabolism in hyperlipidaemic rats. Phytotherapy Res., (1996), 10: 663-665.
13. Kruth, H.S., Lipoprotein cholesterol and atherosclerosis, Curr Mol Med., (2001), 1(6):633-53.
14. La Rosa J.C., Hunninghake D and Bush D,The cholesterol facts; a summary of the evidence relating dietary fats, serum cholesterol and coronary heart diseases. Circulation, (1990), 81(5):1721-1733.
15. Lacoste,L., Jules,Y.T., Lam,Hung J, Letchacovski,G. Solymoss,C. and Waters,D., Hyperlipidemia and Coronary Disease, Circulation, (1995), 92: 3172-3177.
16. Ladislav, D., Paul, S. R., Rat plasma lipoproteins and apolipoproteins in experimental hypothyroidism. Jour. Lipid Res., (1981), 22 : 287-296.
17. Malaspina, J. P., Bussiere, H. and Calve, G.L., The total cholesterol /HDL cholesterol ratio: A suitable atherogenesis index, Atherosclerosis, (1981), 40, 373.
18. Miller, L. A., Botanical influences on cardiovascular diseases, Alternative Medicine Review, (1998), 3(6): 422-431.
19. Moss, J.N and Dajani, E.Z., Screening Methods in Pharmacology,Vol. 2, Academic Press, New York and London,(1971),122-143.
20. NCEP guidelines, Third report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III), Circulation, (2002), 106: 3143-3421.
21. Okhawa, H., Ohisi, N. and Yagi, K., Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem., (1979),95: 351-358.
22. Santillo, M., Migliaro, A., Mondola, P., Laezza, C., Damiano, S., Stingo, S., Fiorentino, L., Andreozzi, A., Vitale, M. and Bifulco, M., Dietary and hypothyroid hypercholesterolemia induces hepatic apolipoprotein E expression in rat: direct role of cholesterol, FEBS Letters, (1999), 463: 83-86.
23. Tohnne, R. and Scott, T., Herbal Support for a healthy cardiovascular system, Clinical Nutrition Insights, (1999), 6(16): 1-5.
24. Toth, P., HDL-C and cardiovascular risk, Circulation, (2004), 109: 1809-1812.
25. Tsai, A.C., Lipid peroxidation and glutathione peroxidase activity in the liver of cholesterol-fed rats, Jour. Nutrition, (1975), 105 : 946-951.
26. Urizar, L.N. and Moore, D.D., Gugulipid: A natural cholesterol lowering agent, Annual Review of Nutrition, (2003), 23: 303-13.
27. Wang, X., Greilberger, J., Ledinski, G., Gerd Kager, Beverly, B. and Jurgens G., The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL, Atherosclerosis, (2004), 172:239-246.
28. Waters, D. and Hsue, P., Low-Density-Lipoprotein Cholesterol Goals for Patients with Coronary Disease: Treating Between the Lines, Circulation, (2001), 104: 2635-2637
29. Willamson, E. Okpako, M., D.T.,Evans F.J., Pharmacological Methods in Phytotherapy Research, (1996), Vol 1,Wiley and Sons Publ., 93-111.